Total Payments
$1.1M
2024 Payments
$126,809
Companies
41
Transactions
1,514
Medicare Patients
4,875
Medicare Billing
$826,968
Payment Breakdown by Category
Other$545,880 (51.0%)
Consulting$383,972 (35.9%)
Travel$77,880 (7.3%)
Food & Beverage$44,009 (4.1%)
Education$18,866 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $416,780 | 124 | 38.9% |
| Consulting Fee | $383,972 | 191 | 35.9% |
| Travel and Lodging | $77,880 | 294 | 7.3% |
| Honoraria | $54,000 | 21 | 5.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $45,850 | 17 | 4.3% |
| Food and Beverage | $44,009 | 855 | 4.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $27,000 | 9 | 2.5% |
| Education | $18,866 | 2 | 1.8% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $2,250 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Oyster Point Pharma, Inc. | $142,731 | 191 | $0 (2024) |
| Shire North American Group Inc | $134,019 | 211 | $0 (2019) |
| Johnson & Johnson Surgical Vision, Inc. | $102,360 | 66 | $0 (2023) |
| Kala Pharmaceuticals, Inc. | $93,993 | 90 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $83,932 | 150 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $74,383 | 147 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $73,618 | 69 | $0 (2024) |
| Allergan, Inc. | $66,786 | 132 | $0 (2022) |
| Dompe US, Inc. | $64,214 | 52 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $41,020 | 48 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $126,809 | 228 | Bausch & Lomb Americas Inc. ($54,192) |
| 2023 | $107,936 | 175 | Oyster Point Pharma, Inc. ($55,562) |
| 2022 | $155,740 | 188 | Oyster Point Pharma, Inc. ($39,780) |
| 2021 | $144,170 | 183 | Kala Pharmaceuticals, Inc. ($34,014) |
| 2020 | $139,107 | 192 | Novartis Pharmaceuticals Corporation ($32,940) |
| 2019 | $213,870 | 260 | Shire North American Group Inc ($48,371) |
| 2018 | $78,781 | 119 | Shire North American Group Inc ($40,064) |
| 2017 | $104,191 | 169 | Shire North American Group Inc ($45,584) |
All Payment Transactions
1,514 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Ophthalmology | ||||||
| 12/23/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $123.91 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/23/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Honoraria | Cash or cash equivalent | $1,750.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $386.82 | General |
| Category: Ophthalmology | ||||||
| 12/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $378.35 | General |
| Category: Ophthalmology | ||||||
| 12/14/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $553.51 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $337.87 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $120.65 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $80.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/09/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Dry eyes | ||||||
| 12/08/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $592.20 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $50.75 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $253.12 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $574.77 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/05/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $223.93 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/05/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $201.20 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/05/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,492 | 1,730 | $1.0M | $235,168 |
| 2022 | 9 | 1,369 | 1,618 | $916,441 | $214,685 |
| 2021 | 10 | 1,003 | 1,227 | $783,729 | $192,798 |
| 2020 | 12 | 1,011 | 1,236 | $755,930 | $184,317 |
Total Patients
4,875
Total Services
5,811
Medicare Billing
$826,968
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 186 | 289 | $596,886 | $132,208 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 383 | 398 | $139,419 | $36,234 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 166 | 166 | $75,178 | $19,404 | 25.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 49 | 57 | $74,248 | $15,715 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 167 | $41,491 | $11,636 | 28.0% |
| 92134 | Imaging of retina | Office | 2023 | 238 | 255 | $34,792 | $7,726 | 22.2% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 189 | 208 | $32,725 | $7,045 | 21.5% |
| 92025 | Ct scan of cornea | Office | 2023 | 165 | 170 | $20,752 | $4,619 | 22.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 20 | 20 | $2,477 | $579.78 | 23.4% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 143 | 228 | $470,863 | $103,016 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 362 | 385 | $134,881 | $35,633 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 232 | 232 | $105,015 | $28,055 | 26.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 54 | 65 | $85,931 | $18,186 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 206 | $51,149 | $14,320 | 28.0% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 144 | 165 | $24,793 | $5,711 | 23.0% |
| 92134 | Imaging of retina | Office | 2022 | 172 | 180 | $24,558 | $5,575 | 22.7% |
| 92025 | Ct scan of cornea | Office | 2022 | 112 | 115 | $14,050 | $3,017 | 21.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 41 | 42 | $5,201 | $1,172 | 22.5% |
| 66984 | Removal of cataract with insertion of lens, simple | Facility | 2021 | 129 | 202 | $413,990 | $93,322 | 22.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 369 | 393 | $137,379 | $38,624 | 28.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 197 | 197 | $88,467 | $24,309 | 27.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 129 | 248 | $61,167 | $17,442 | 28.5% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Office | 2021 | 42 | 47 | $60,670 | $13,511 | 22.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 47 | 48 | $6,467 | $1,568 | 24.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $5,098 | $1,373 | 26.9% |
About Dr. Francis Mah, MD
Dr. Francis Mah, MD is a Specialist healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528032620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francis Mah, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $126,809 received in 2024. These payments were reported across 1,514 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($416,780).
As a Medicare-enrolled provider, Mah has provided services to 4,875 Medicare beneficiaries, totaling 5,811 services with total Medicare billing of $826,968. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Pittsburgh, PA
- Active Since 02/15/2006
- Last Updated 06/28/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1528032620
Products in Payments
- XIIDRA (Drug) $156,430
- TYRVAYA (Drug) $142,678
- INVELTYS (Drug) $45,328
- ACTHAR (Biological) $42,704
- EYSUVIS (Drug) $42,016
- Cequa (Drug) $40,787
- Catalys Laser System (Device) $37,067
- MIEBO (Drug) $32,989
- OXERVATE (Drug) $31,011
- Tecnis 1-piece IOL (Device) $28,521
- BLENREP (Biological) $28,439
- Oxervate (Drug) $28,304
- CEQUA (Drug) $23,227
- ZYLET (Drug) $22,006
- VUITY (Drug) $21,042
- Compact Intuitiv (Device) $14,275
- Tecnis Multifocal Family of 1-piece IOLS (Device) $12,338
- ORA (Device) $10,984
- STELLARIS ELITE (Device) $10,690
- CEQUA (cyclosporine ophthalmic solution) 0.09% (Drug) $8,327
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Pittsburgh
Dr. Lawrence Crossett, Md, MD
Specialist — Payments: $5.3M
Specialist $5.3M
Dr. James Bradley, Md, MD
Specialist — Payments: $5.0M
Specialist $5.0M
Darrell Triulzi
Specialist — Payments: $3.3M
Specialist $3.3M
Dr. Mark Yazer, Md, MD
Specialist — Payments: $2.4M
Specialist $2.4M
Lirong Qu
Specialist — Payments: $2.4M
Specialist $2.4M
Dr. Miguel Regueiro, Md, MD
Specialist — Payments: $1.4M
Specialist $1.4M